End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.31 CNY | -1.60% | +3.11% | -1.60% |
Apr. 25 | Fuan Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2023 | CI |
Apr. 24 | Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2022 | 2.42B 335M | Sales 2023 | 2.65B 367M | Capitalization | 5.21B 721M |
---|---|---|---|---|---|
Net income 2022 | 205M 28.38M | Net income 2023 | 232M 32.11M | EV / Sales 2022 | 1.77 x |
Net Debt 2022 | 10.45M 1.45M | Net cash position 2023 | 104M 14.4M | EV / Sales 2023 | 1.93 x |
P/E ratio 2022 |
21.2
x | P/E ratio 2023 |
23.1
x | Employees | 3,292 |
Yield 2022 |
1.39% | Yield 2023 |
1.14% | Free-Float | 17.16% |
1 day | -1.60% | ||
1 week | +3.11% | ||
Current month | +3.11% | ||
1 month | +9.11% | ||
3 months | +24.57% | ||
6 months | -6.10% | ||
Current year | -1.60% |
Managers | Title | Age | Since |
---|---|---|---|
Lu Wang
CEO | Chief Executive Officer | 40 | 21-12-09 |
Xue Song Yu
DFI | Director of Finance/CFO | 55 | 09-09-18 |
Tian Xiang Wang
CHM | Chairman | 68 | 09-09-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tian Xiang Wang
CHM | Chairman | 68 | 09-09-18 |
Qin Tang
BRD | Director/Board Member | 55 | 09-09-18 |
Zi Wei Guo
BRD | Director/Board Member | 54 | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 0 M€ | +3.63% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 4.31 | -1.60% | 41,552,700 |
24-05-09 | 4.38 | 0.00% | 52,028,920 |
24-05-08 | 4.38 | -0.45% | 56,540,400 |
24-05-07 | 4.4 | +2.80% | 74,411,000 |
End-of-day quote Shenzhen S.E., May 09, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-1.60% | 710M | |
+19.62% | 43.27B | |
+24.52% | 22.92B | |
+20.29% | 15.43B | |
+7.48% | 12.95B | |
+42.51% | 11.83B | |
-8.84% | 6.91B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.55B |
- Stock Market
- Equities
- 300194 Stock